Lumos Diagnostics logo
LDXLumos Diagnostics
Trade LDX now
Lumos Diagnostics primary media

About Lumos Diagnostics

Lumos Diagnostics (ASX:LDX) is a molecular diagnostics company that develops, manufactures, and sells rapid, accurate, and easy-to-use diagnostic tests. The company's products are used in a variety of settings, including hospitals, clinics, and laboratories. Lumos's flagship product is the Lumos Platform, which is a portable, battery-powered device that can perform a variety of diagnostic tests in minutes. Lumos is currently working on a number of projects, including the development of new tests for a variety of diseases, as well as the expansion of its Lumos Platform into new markets.

What is LDX known for?

Snapshot

Public AU
Ownership
2004
Year founded
52
Employees
California, United States
Head office
1 of 50
AU Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Products and/or services of Lumos Diagnostics

  • Point-of-care Assays: Lumos oversees the complete POC assay development process, from reagent acquisition to validation, including expertise gained from the recent acquisition of Kestrel BioSciences.
  • Point-of-care- Readers: leveraging its market expertise to create adaptable POC reader platforms, allowing seamless customization to match partner specifications.
  • Cloud and Data Management: offers a comprehensive cloud interface for POC device data, ensuring secure storage and enabling insightful analytics for partners.
  • POC Diagnostic Product Manufacturing: ISO 13485 certified OEM manufacturing facility, strategically integrated with its technical R&D team to expedite the transition to production and ensure continued support.

Lumos Diagnostics executive team

  • Mr. Douglas WardCEO, MD & Director
  • Mr. Barrie LambertChief Financial Officer
  • Mr. Anthony FavaloroVP of Operations
  • Dr. Sacha Dopheide Ph.D.Chief Technology Officer
  • Ms. Sarah GlubkaVice President of Human Resources
  • Mr. Paul KaseSenior Vice President of Commercial Operations
  • Ms. Tracy Weimar BA, MBACompany Secretary
  • Ms. Annie BellVice President of Medical Affairs
  • Amelia StephensGlobal Marketing and Awareness Consultant

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.